Preeclampsia: the death of Goliath (Q36376515)

13 August 2017

1 reference

title

Preeclampsia: the death of Goliath (English)

1 reference

13 August 2017

0 references

Bruce B Feinberg

1

1 reference

13 August 2017

1 February 2006

1 reference

American Journal of Reproductive Immunology

13 August 2017

1 reference

13 August 2017

55

1 reference

13 August 2017

2

1 reference

13 August 2017

84-98

1 reference

Maternal morbidity and obstetric complications in triplet pregnancies and quadruplet and higher-order multiple pregnancies.

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Paternal and maternal components of the predisposition to preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Trophoblast deportation and the maternal inflammatory response in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Placental debris, oxidative stress and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Preeclampsia: an endothelial cell disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Eicosanoids in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Amino thiols, detoxification and oxidative stress in pre-eclampsia and other disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Pre-eclampsia and the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Preeclampsia: an excessive maternal inflammatory response to pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Immunoglobulin Deposition in the Kidney in Pre-Eclampsia: Its Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

The role of complement in pregnancy-induced hypertensive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

The formation of immune complexes in primiparous and multiparous human pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Immunological studies on pre-eclampsia in Nigerian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Pharmacokinetics and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

The role of the complement system in ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Complement C5a receptor antagonist attenuates multiple organ injury in a model of ruptured abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

A convergent solution-phase synthesis of the macrocycle Ac-Phe-[Orn-Pro-D-Cha-Trp-Arg], a potent new antiinflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

The machinery of programmed cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Macrophages and apoptotic cell clearance during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

B cells as therapeutic targets for rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Side effects of corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Review article: the limitations of corticosteroid therapy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

New cytokine therapeutics for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

World Health Organization systematic review of screening tests for preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Immune complexes and vasoactivity generated from platelets in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Urinary Placental Growth Factor and Risk of Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Inhibition of Heparin/Protamine Complex-Induced Complement Activation by Compstatin in Baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

Immune complexes in preeclampsia and normal pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00362.X

10.1111/J.1600-0897.2005.00362.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16433827